Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 9/2014

01.09.2014 | Laryngology

European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer

verfasst von: Ricard Simo, Patrick Bradley, Dominique Chevalier, Frederik Dikkers, Hans Eckel, Nayla Matar, Giorgio Peretti, Cesare Piazza, Mark Remacle, Miquel Quer

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

It is accepted that the follow-up of patients who had treatment for laryngeal cancer is a fundamental part of their care. The reasons of post-treatment follow-up include evaluation of treatment response, early identification of recurrence, early detection of new primary tumours, monitoring and management of complications, optimisation of rehabilitation, promotion smoking and excessive alcohol cessation, provision of support to patients and their families, patient counselling and education. Controversies exist in how these aims are achieved. Increasing efforts are being made to rationalise the structure and timing of head and neck cancer follow-up clinics. The aim of this document is to analyse the current evidence for the need to follow up patients who have been treated for LC and provide an up to date, evidence-based statement which is meaningful and applicable to all European Health Care Systems. A working group of the Head and Neck Cancer Committee of the ELS was constituted in 2009. A review of the current published literature on the management and follow-up of laryngeal cancer was undertaken and statements are made based on critical appraisal of the literature and best current evidence. Category recommendations were based on the Oxford Centre for Evidence-Based Medicine. Statements include: length, frequency, setting, type of health professional, clinical assessment, screening investigations, patient’s education, second primary tumours, and mode of treatment considerations including radiotherapy, chemo-radiation therapy, transoral surgery and open surgery. It also addresses specific recommendations regarding patients with persistent pain, new imaging techniques, tumour markers and narrow band imaging.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4):765–781CrossRefPubMed Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4):765–781CrossRefPubMed
3.
Zurück zum Zitat Brugere J, Guenel P, Leclerc A, Rodriguez J (1986) Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer 57:391–395CrossRefPubMed Brugere J, Guenel P, Leclerc A, Rodriguez J (1986) Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer 57:391–395CrossRefPubMed
4.
Zurück zum Zitat Graham S, Mettlin C, Marshall J, Priore R, Rzepka T, Shedd D (1981) Dietary factors in the epidemiology of cancer of the larynx. Am J Epidemiol 113:675–680PubMed Graham S, Mettlin C, Marshall J, Priore R, Rzepka T, Shedd D (1981) Dietary factors in the epidemiology of cancer of the larynx. Am J Epidemiol 113:675–680PubMed
5.
Zurück zum Zitat Hellquist H, Lundgren J, Olofsson J (1982) Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords: a follow-up study. Clin Otolaryngol 7:11–27CrossRefPubMed Hellquist H, Lundgren J, Olofsson J (1982) Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords: a follow-up study. Clin Otolaryngol 7:11–27CrossRefPubMed
7.
Zurück zum Zitat Ferlito A, Bradley PJ, Rinaldo A (2009) Laryngeal epithelial changes: diagnosis and therapy, chapter 20. In: Fried MP, Ferlito A (eds) The larynx, 3rd edn. Plural Publishing, San Diego Ferlito A, Bradley PJ, Rinaldo A (2009) Laryngeal epithelial changes: diagnosis and therapy, chapter 20. In: Fried MP, Ferlito A (eds) The larynx, 3rd edn. Plural Publishing, San Diego
8.
Zurück zum Zitat Sobin LH, Wittwkind Ch (eds) (2008) TNM classification of malignant tumours, 7th edn. Wiley-Liss Publishers, New York Sobin LH, Wittwkind Ch (eds) (2008) TNM classification of malignant tumours, 7th edn. Wiley-Liss Publishers, New York
9.
Zurück zum Zitat Roland NJ, Paleri V (eds) (2011) Head and neck cancer; multidisciplinary management guidelines, 4th edn. London ENT, UK Roland NJ, Paleri V (eds) (2011) Head and neck cancer; multidisciplinary management guidelines, 4th edn. London ENT, UK
10.
Zurück zum Zitat Joshi A, Jeannon JP, Pracy P, O’Connell M, Simo R (2010) Current trends in the follow-up of head and neck patients in the United Kingdom. Clin Oncol 22(2):114–118CrossRef Joshi A, Jeannon JP, Pracy P, O’Connell M, Simo R (2010) Current trends in the follow-up of head and neck patients in the United Kingdom. Clin Oncol 22(2):114–118CrossRef
11.
Zurück zum Zitat Digonnet A, Hamoir M, Andry G, Haigenz M, Takes RP, Vander Poorten V, Haigenz M Jr, Langendijk JA, de Bree R, Hinni ML, Rodrigo JP, Suarez C, Mendanhall WM, Rinaldo A, Werner JA, Takes RP, Ferlito A (2013) Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 270(7):1569–1580CrossRefPubMed Digonnet A, Hamoir M, Andry G, Haigenz M, Takes RP, Vander Poorten V, Haigenz M Jr, Langendijk JA, de Bree R, Hinni ML, Rodrigo JP, Suarez C, Mendanhall WM, Rinaldo A, Werner JA, Takes RP, Ferlito A (2013) Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 270(7):1569–1580CrossRefPubMed
12.
Zurück zum Zitat Digonnet A, Hamoir M, Andry G, Vander Poorten V, Haigenz M Jr, Langendijk JA, de Bree R, Hinni ML, Mendanhall WM, Paleri V, Rinaldo A, Werner JA, Takes RP, Ferlito A (2013) Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma. Eur Arch Otorhinolaryngol 270(7):1981–1989CrossRefPubMed Digonnet A, Hamoir M, Andry G, Vander Poorten V, Haigenz M Jr, Langendijk JA, de Bree R, Hinni ML, Mendanhall WM, Paleri V, Rinaldo A, Werner JA, Takes RP, Ferlito A (2013) Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma. Eur Arch Otorhinolaryngol 270(7):1981–1989CrossRefPubMed
13.
Zurück zum Zitat Haas I, Hauser U, Ganzer U (2001) The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 258:177–183CrossRefPubMed Haas I, Hauser U, Ganzer U (2001) The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 258:177–183CrossRefPubMed
14.
15.
Zurück zum Zitat Morton R, David Hay K, Macann A (2004) On completion of curative treatment of head and neck cancer: why follow up? Curr Opin Otol 12:142–146CrossRef Morton R, David Hay K, Macann A (2004) On completion of curative treatment of head and neck cancer: why follow up? Curr Opin Otol 12:142–146CrossRef
16.
Zurück zum Zitat Boysen M, Lovdal O, Tausjo J et al (1992) The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 23:426–430CrossRef Boysen M, Lovdal O, Tausjo J et al (1992) The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 23:426–430CrossRef
17.
Zurück zum Zitat Virgo KS, Paniello RC, Johnson FE (1998) Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer. Arch Otolaryngol Head Neck Surg 124:564–572CrossRefPubMed Virgo KS, Paniello RC, Johnson FE (1998) Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer. Arch Otolaryngol Head Neck Surg 124:564–572CrossRefPubMed
18.
Zurück zum Zitat van Agthoven M, van Inevald BM, de Boer MF et al (2001) The costs of head and neck oncology: primary tumors, recurrent tumors and long term follow up. Eur J Cancer 37:2204–2211CrossRefPubMed van Agthoven M, van Inevald BM, de Boer MF et al (2001) The costs of head and neck oncology: primary tumors, recurrent tumors and long term follow up. Eur J Cancer 37:2204–2211CrossRefPubMed
19.
Zurück zum Zitat Tuttle RM, Leboeuf R (2008) Follow-up approaches in thyroid cancer: a risk adapted paradigm. Endocrinol Metab Clin N Am 37(2):419–435CrossRef Tuttle RM, Leboeuf R (2008) Follow-up approaches in thyroid cancer: a risk adapted paradigm. Endocrinol Metab Clin N Am 37(2):419–435CrossRef
20.
Zurück zum Zitat Tuttle RM (2008) Follow-up approaches in thyroid cancer: a risk adapted paradigm. Endocr Pract 14(6):764–774CrossRefPubMed Tuttle RM (2008) Follow-up approaches in thyroid cancer: a risk adapted paradigm. Endocr Pract 14(6):764–774CrossRefPubMed
21.
Zurück zum Zitat Oxford Centre for Evidence-based Medicine Levels of Evidence (2011) Centre for Evidence Based Medicine University of Oxford Oxford Centre for Evidence-based Medicine Levels of Evidence (2011) Centre for Evidence Based Medicine University of Oxford
22.
Zurück zum Zitat Sardell S, Sharpe G, Ashley S et al (2000) Evaluation of a nurse-led telephone clinic in the follow-up of patients with malignant glioma. Clin Oncol 12:36–41 Sardell S, Sharpe G, Ashley S et al (2000) Evaluation of a nurse-led telephone clinic in the follow-up of patients with malignant glioma. Clin Oncol 12:36–41
23.
Zurück zum Zitat Cox K, Wilson E (2003) Follow-up for people with cancer: nurse-led services and telephone Interventions. J Adv Nurs 43(1):51–61CrossRefPubMed Cox K, Wilson E (2003) Follow-up for people with cancer: nurse-led services and telephone Interventions. J Adv Nurs 43(1):51–61CrossRefPubMed
24.
Zurück zum Zitat Gugatschka M, Kiesler K, Beham A, Rechenmacher J, Friedrich G (2008) Hyperplastic epithelial lesions of the vocal folds: combined use of exfoliative cytology and laryngostroboscopy in differential diagnosis. Eur Arch Otorhinolaryngol 265(7):797–801CrossRefPubMed Gugatschka M, Kiesler K, Beham A, Rechenmacher J, Friedrich G (2008) Hyperplastic epithelial lesions of the vocal folds: combined use of exfoliative cytology and laryngostroboscopy in differential diagnosis. Eur Arch Otorhinolaryngol 265(7):797–801CrossRefPubMed
25.
Zurück zum Zitat Paul BC, Chen S, Sridharan S, Fang Y, Amin MR, Branski RC (2013) Diagnostic accuracy of history, laryngoscopy, and stroboscopy. Laryngoscope 123(1):215–219CrossRefPubMed Paul BC, Chen S, Sridharan S, Fang Y, Amin MR, Branski RC (2013) Diagnostic accuracy of history, laryngoscopy, and stroboscopy. Laryngoscope 123(1):215–219CrossRefPubMed
26.
Zurück zum Zitat Chong V, Fan Y-F (1997) Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology 202:463–470CrossRefPubMed Chong V, Fan Y-F (1997) Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology 202:463–470CrossRefPubMed
27.
Zurück zum Zitat Ul-Hassan F, Simo R, Guerrero-Urbano T, Oakley R, Jeannon JP, Cook GJ (2013) Can (18)F-FDG PET/CT reliably assess response to primary treatment of head and neck cancer? Clin Nucl Med 38(4):263–265CrossRefPubMed Ul-Hassan F, Simo R, Guerrero-Urbano T, Oakley R, Jeannon JP, Cook GJ (2013) Can (18)F-FDG PET/CT reliably assess response to primary treatment of head and neck cancer? Clin Nucl Med 38(4):263–265CrossRefPubMed
28.
Zurück zum Zitat Isles MG, McConkey C, Mehanna HM (2008) A systematic review and meta-analysis of the role of positron emission tomography in the follow-up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 33:210–222CrossRefPubMed Isles MG, McConkey C, Mehanna HM (2008) A systematic review and meta-analysis of the role of positron emission tomography in the follow-up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 33:210–222CrossRefPubMed
29.
Zurück zum Zitat Brouwer J, Hooft L, Hoekstra OS, Riphagen II, Castelijns JA, de Bree R, Leemans CR (2008) Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck 30(7):889–897CrossRefPubMed Brouwer J, Hooft L, Hoekstra OS, Riphagen II, Castelijns JA, de Bree R, Leemans CR (2008) Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck 30(7):889–897CrossRefPubMed
30.
Zurück zum Zitat Kothari P, Trinidade A, Hewitt RJD, Singh A, O’Flynn P (2011) The follow-up of patients with head and neck cancer: an analysis of 1039 patients. Eur Arch Otorhinolaryngol 268:1191–1200CrossRefPubMed Kothari P, Trinidade A, Hewitt RJD, Singh A, O’Flynn P (2011) The follow-up of patients with head and neck cancer: an analysis of 1039 patients. Eur Arch Otorhinolaryngol 268:1191–1200CrossRefPubMed
31.
Zurück zum Zitat Trinidade A, Kothari P, Andreou Z, Hewitt RJ, O’Flynn P (2012) Follow-up in head and neck cancer: patients’ perspective. Int J Health Care Qual Assur 25(2):145–149CrossRefPubMed Trinidade A, Kothari P, Andreou Z, Hewitt RJ, O’Flynn P (2012) Follow-up in head and neck cancer: patients’ perspective. Int J Health Care Qual Assur 25(2):145–149CrossRefPubMed
32.
Zurück zum Zitat León X, Quer M, Diez S, Orús C, López-Pousa A, Burgués J (1999) Second neoplasm in patients with head and neck cancer. Head Neck 21:204–210CrossRefPubMed León X, Quer M, Diez S, Orús C, López-Pousa A, Burgués J (1999) Second neoplasm in patients with head and neck cancer. Head Neck 21:204–210CrossRefPubMed
33.
Zurück zum Zitat León X, Quer M, Orús C, Venegas MP (2001) Can cure be achieved in patients with head and neck carcinomas? The problem of second neoplasm. Expert Rev Anticancer Ther 1:125–133CrossRefPubMed León X, Quer M, Orús C, Venegas MP (2001) Can cure be achieved in patients with head and neck carcinomas? The problem of second neoplasm. Expert Rev Anticancer Ther 1:125–133CrossRefPubMed
34.
Zurück zum Zitat Leon X, Del Prado Venegas M, Orus C, Kolanczak K, Garcia J, Quer M (2005) Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol 262:905–909CrossRefPubMed Leon X, Del Prado Venegas M, Orus C, Kolanczak K, Garcia J, Quer M (2005) Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol 262:905–909CrossRefPubMed
35.
Zurück zum Zitat León X, Venegas MD, Orús C, López M, García J, Quer M (2009) Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study. Cancer Causes Control 20:645–652CrossRefPubMed León X, Venegas MD, Orús C, López M, García J, Quer M (2009) Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study. Cancer Causes Control 20:645–652CrossRefPubMed
36.
Zurück zum Zitat León X, Martínez V, López M, García J, Quer M (2010) Risk of third and fourth tumors in patients with head and neck cancer. Head Neck 32:1467–1472CrossRefPubMed León X, Martínez V, López M, García J, Quer M (2010) Risk of third and fourth tumors in patients with head and neck cancer. Head Neck 32:1467–1472CrossRefPubMed
37.
Zurück zum Zitat Di Martino E, Sellhaus B, Hausmann R et al (2002) Survival in second primary malignancies in head and neck cancer patients. J Laryngol Otol 116(10):831–838CrossRefPubMed Di Martino E, Sellhaus B, Hausmann R et al (2002) Survival in second primary malignancies in head and neck cancer patients. J Laryngol Otol 116(10):831–838CrossRefPubMed
38.
Zurück zum Zitat O’Meara W, Thiringer J, Johnstone P (2003) Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol 66:323–326CrossRefPubMed O’Meara W, Thiringer J, Johnstone P (2003) Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol 66:323–326CrossRefPubMed
39.
Zurück zum Zitat Schwartz D, Barker J, Chansky K et al (2003) Postradiothearapy surveillance practice for head and neck squamous cell carcinoma—too much for too little. Head Neck 25:990–999CrossRefPubMed Schwartz D, Barker J, Chansky K et al (2003) Postradiothearapy surveillance practice for head and neck squamous cell carcinoma—too much for too little. Head Neck 25:990–999CrossRefPubMed
40.
Zurück zum Zitat Lapela M, Eigtved A, Jyrkkio S et al (2000) Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 36:858–867CrossRefPubMed Lapela M, Eigtved A, Jyrkkio S et al (2000) Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 36:858–867CrossRefPubMed
41.
Zurück zum Zitat Manikantan K, Khode S, Dwivedi R, Palav R, Nutting C, Rhys-Evans P, Harrington K, Kazi R (2009) Making sense of post treatment surveillance in head and neck cancer: when and what of follow-up. Cancer Treat Rev 35:744–753CrossRefPubMed Manikantan K, Khode S, Dwivedi R, Palav R, Nutting C, Rhys-Evans P, Harrington K, Kazi R (2009) Making sense of post treatment surveillance in head and neck cancer: when and what of follow-up. Cancer Treat Rev 35:744–753CrossRefPubMed
42.
Zurück zum Zitat Goguen L, Chapuy C, Sher D et al (2010) Utilizing computed tomography as a road map for designing selective and superselective neck dissection after chemoradiotherapy. Otolaryngol Head Neck Surg 143:367–374CrossRefPubMed Goguen L, Chapuy C, Sher D et al (2010) Utilizing computed tomography as a road map for designing selective and superselective neck dissection after chemoradiotherapy. Otolaryngol Head Neck Surg 143:367–374CrossRefPubMed
43.
Zurück zum Zitat Bakhshndeh M, Hashemi B, Mahdavi SR, Nikoofar A, Vasheghani M, Kazemnejad A (2013) Normal tissue complication probability modelling of radiation-induced hypothyroidism after head and neck radiation therapy. Int J Radiat Oncol Biol Phys 85(2):514–521CrossRef Bakhshndeh M, Hashemi B, Mahdavi SR, Nikoofar A, Vasheghani M, Kazemnejad A (2013) Normal tissue complication probability modelling of radiation-induced hypothyroidism after head and neck radiation therapy. Int J Radiat Oncol Biol Phys 85(2):514–521CrossRef
44.
Zurück zum Zitat Vogelius IR, Bentzen SM, Maraldo MV, Petersen PM, Specht L (2011) Risk factors for radiation-induced hypothyroidism. Cancer 117:5252–5260CrossRef Vogelius IR, Bentzen SM, Maraldo MV, Petersen PM, Specht L (2011) Risk factors for radiation-induced hypothyroidism. Cancer 117:5252–5260CrossRef
45.
Zurück zum Zitat van Gogh CD, Verdonck-de Leeuw IM, Langendijk JA, Kuik DJ, Mahieu HF (2012) Long-term efficacy of voice therapy in patients with voice problems after treatment of early glottic cancer. Eur Arch Otorhinolaryngol 269(6):1647–1652PubMedCentralCrossRefPubMed van Gogh CD, Verdonck-de Leeuw IM, Langendijk JA, Kuik DJ, Mahieu HF (2012) Long-term efficacy of voice therapy in patients with voice problems after treatment of early glottic cancer. Eur Arch Otorhinolaryngol 269(6):1647–1652PubMedCentralCrossRefPubMed
46.
Zurück zum Zitat Roh J-L, Kim D-H, Park CI (2008) The utility of second-look operation after laser microresection of glottic carcinoma involving the anterior commissure. Laryngoscope 118:1400–1404CrossRefPubMed Roh J-L, Kim D-H, Park CI (2008) The utility of second-look operation after laser microresection of glottic carcinoma involving the anterior commissure. Laryngoscope 118:1400–1404CrossRefPubMed
47.
Zurück zum Zitat Preuss SF, Cramer K, Drebber U et al (2009) Second-look microlaryngoscopy to detect residual carcinoma in patients after laser surgery for T1 and T2 laryngeal cancer. Acta Otolaryngol 129:881–885CrossRefPubMed Preuss SF, Cramer K, Drebber U et al (2009) Second-look microlaryngoscopy to detect residual carcinoma in patients after laser surgery for T1 and T2 laryngeal cancer. Acta Otolaryngol 129:881–885CrossRefPubMed
48.
Zurück zum Zitat Keilmann A, Napiontek U, Engel C, Nakarat T, Schneider A, Mann W (2011) Long-term functional outcome after unilateral cordectomy. ORL J Otorhinolaryngol Relat Spec 73(1):38–46CrossRefPubMed Keilmann A, Napiontek U, Engel C, Nakarat T, Schneider A, Mann W (2011) Long-term functional outcome after unilateral cordectomy. ORL J Otorhinolaryngol Relat Spec 73(1):38–46CrossRefPubMed
49.
Zurück zum Zitat Smit M, Balm AJ, Hilgers FJ et al (2001) Pain as sign of recurrent disease in head and neck squamous cell carcinoma. Head Neck Surg 23:372–375CrossRef Smit M, Balm AJ, Hilgers FJ et al (2001) Pain as sign of recurrent disease in head and neck squamous cell carcinoma. Head Neck Surg 23:372–375CrossRef
50.
Zurück zum Zitat Scharpf J, Karnell LH, Christensen AJ et al (2009) The role of pain in head and neck cancer recurrence and survivorship. Arch Otolaryngol Head Neck Surg 135:789–794CrossRefPubMed Scharpf J, Karnell LH, Christensen AJ et al (2009) The role of pain in head and neck cancer recurrence and survivorship. Arch Otolaryngol Head Neck Surg 135:789–794CrossRefPubMed
51.
Zurück zum Zitat Vandecaveye V, De Keyzer F, Nuyts S et al (2007) Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67:960–971CrossRefPubMed Vandecaveye V, De Keyzer F, Nuyts S et al (2007) Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67:960–971CrossRefPubMed
52.
Zurück zum Zitat Abdel Razek AA, Kandeel AY, Soliman N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 28:1146–1152CrossRefPubMed Abdel Razek AA, Kandeel AY, Soliman N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 28:1146–1152CrossRefPubMed
53.
Zurück zum Zitat Abdel Razek AA, Megahed AS, Denewer A et al (2008) Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors. Acta Radiol 49:364–370CrossRef Abdel Razek AA, Megahed AS, Denewer A et al (2008) Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors. Acta Radiol 49:364–370CrossRef
54.
Zurück zum Zitat Gold KA, Kim ES (2009) Role of molecular markers and gene profiling in head and neck cancers. Curr Opin Oncol 21:206–211CrossRefPubMed Gold KA, Kim ES (2009) Role of molecular markers and gene profiling in head and neck cancers. Curr Opin Oncol 21:206–211CrossRefPubMed
55.
Zurück zum Zitat Braakhuis BJM, Brakenhoff RH, Leemans CR (2010) Gene expression profiling in head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg 18:67–71CrossRefPubMed Braakhuis BJM, Brakenhoff RH, Leemans CR (2010) Gene expression profiling in head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg 18:67–71CrossRefPubMed
56.
Zurück zum Zitat Piazza C, Del Bon F, Peretti G, Nicolai P (2012) Narrow band imaging in endoscopic evaluation of the larynx. Curr Opin Otolaryngol Head Neck Surg 20(6):472–476CrossRefPubMed Piazza C, Del Bon F, Peretti G, Nicolai P (2012) Narrow band imaging in endoscopic evaluation of the larynx. Curr Opin Otolaryngol Head Neck Surg 20(6):472–476CrossRefPubMed
57.
Zurück zum Zitat Piazza C (2011) Is narrow band imaging the ideal screening tool for mucosal head and neck cancer. Oral Oncol 47(5):313CrossRefPubMed Piazza C (2011) Is narrow band imaging the ideal screening tool for mucosal head and neck cancer. Oral Oncol 47(5):313CrossRefPubMed
58.
Zurück zum Zitat Piazza C, Cocco D, De Benedetto L, Del Bon F, Nicolai P, Peretti G (2010) Narrow band imaging and high definition television in the assessment of laryngeal cancer: a prospective study on 279 patients. Eur Arch Otorhinolaryngol 267(3):409–414CrossRefPubMed Piazza C, Cocco D, De Benedetto L, Del Bon F, Nicolai P, Peretti G (2010) Narrow band imaging and high definition television in the assessment of laryngeal cancer: a prospective study on 279 patients. Eur Arch Otorhinolaryngol 267(3):409–414CrossRefPubMed
59.
Zurück zum Zitat Sobin L, Gospondarowicz M, Wittekind C (eds) (2009) TNM classification of malignant tumours, 7th edn. Blackwell, Oxford Sobin L, Gospondarowicz M, Wittekind C (eds) (2009) TNM classification of malignant tumours, 7th edn. Blackwell, Oxford
Metadaten
Titel
European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer
verfasst von
Ricard Simo
Patrick Bradley
Dominique Chevalier
Frederik Dikkers
Hans Eckel
Nayla Matar
Giorgio Peretti
Cesare Piazza
Mark Remacle
Miquel Quer
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 9/2014
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-014-2966-x

Weitere Artikel der Ausgabe 9/2014

European Archives of Oto-Rhino-Laryngology 9/2014 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.